The Healthcare Commercialization Journey – Stories from entrepreneurs who have been there, or are on their wayJLABS @ TorontoThursday, April 12, 2018 from 4:00 PM to 8:00 PM (EDT) |
|
Event Details
Successful innovation in healthcare requires navigating a long and challenging journey. It takes dedication, time and ultimately perseverance to forge into the unknown and disrupt the healthcare industry.
Join us at JLABS @ Toronto to hear from a variety of panels with life science entrepreneurs who will discuss their technology, journey and successes.
Panels:
From Research to Incorporation
It is important to translate healthcare innovations from academia into commercialization. It is up to the scientists and graduate students to move scientific discoveries from the lab to market. Hear from three entrepreneurs who started their companies in a hospital or academic lab and why they chose to incorporate.
Panelists: Sean Kidd, Co-founder, A4i; Roderick Slavcev, CEO, Mediphage Bioceuticals; Christine Allen, Co-founder & President, Nanovista
Moderator: Allan Miranda, Head, JLABS Canada
Getting Closer to Commercialization in Biotech
A new partnership, a Series A raised and a 510k clearance – the last year for these three companies has been significant. Let’s explore how they got where they are and where they’re going next.
Panelists: Chris Barden, CEO, Treventis Corporation; Michael Scott, Sr. Vice President, Product Development & Toronto Operations, BlueRock Therapeutics; Lionel Lenkinski, CEO, NerveVision
Moderator: Rebecca Yu, Vice President, Market Access & External Affairs, Takeda Canada Inc.
Launching a Consumer Health Product
Today, we are taking an increasingly active role in managing our own health. As a result, the demand for consumer healthcare products is growing. These start-ups took advantage of market trends and developed products all of which are currently for sale. Learn how they navigated the road to retail and brought their consumer health products to market.
Panelists: Ted Jin, CEO, Dosebiome; Jessica Ching, Co-founder & CEO, Eve Medical; Andrew Martinko, Co-founder & CEO, Suncayr
Moderator: Stefanie Dhanda, Senior Director, Scientific Innovation, Consumer, Johnson & Johnson Innovation
Commercializing Artificial Intelligence
Artificial intelligence (AI) poses unlimited opportunity for us to make a transformative impact on patients. AI could save scientists valuable research time and bring new treatments to patients more quickly. Learn how these three companies are driving the adoption and commercialization of AI technologies through their work.
Panelists: Naheed Kurji, CEO, Cyclica; Shelley Boyd, CEO, Tracery Ophthalmics; Liam Kaufman, CEO, Winterlight Labs
Moderator: Erhan Soyer-Osman, Venture Capital, Two Sigma Ventures
Agenda
4:00pm | Registration
4:15pm | Panel 1: From Research to Incorporation
4:55pm | Panel 2: Getting Closer to Commercialization in Biotech
5:35pm | Break
5:45pm | Panel 3: Launching a Consumer Health Product
6:25pm | Panel 4: Commercializing Artificial Intelligence
7:00pm | Networking
8:00pm | Program Close
Fees
FREE | General Public
Location
JLABS @ Toronto
661 University Ave, Suite 1300
Toronto, Ontario
When & Where
JLABS @ Toronto
661 University Ave
Suite 1300
Toronto,
ON M5G 1M1
Canada
Thursday, April 12, 2018 from 4:00 PM to 8:00 PM (EDT)
Add to my calendar
Organizer
JLABS @ Toronto
About Johnson & Johnson Innovation, JLABS
Johnson & Johnson Innovation, JLABS (JLABS) is a global network of open innovation ecosystems, enabling and empowering innovators to create and accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients around the world. JLABS achieves this by providing the optimal environment for emerging companies to catalyze growth and optimize their research and development by opening them to vital industry connections, delivering entrepreneurial programs and providing a capital-efficient, flexible platform where they can transform the scientific discoveries of today into the breakthrough healthcare solutions of tomorrow. At JLABS we value great ideas and are passionate about removing obstacles to success to help innovators unleash the potential of their early scientific discoveries. JLABS is a no-strings-attached model, which means entrepreneurs are free to develop their science while holding on to their intellectual property. JLABS is open to entrepreneurs across a broad healthcare spectrum including pharmaceutical, medical device, consumer and healthtech sectors. The JLABS flagship opened in 2012 in San Diego at Janssen's West Coast Research Center, and since then has grown to ten global locations including the Bay Area, Boston & Lowell, MA, Houston, Toronto, Beerse (Belgium), with New York City, opening in June 2018, and Shanghai in 2019. For more information please visit www.jlabs.jnjinnovation.com or follow @JLABS.
About Johnson & Johnson Innovation
Johnson & Johnson Innovation focuses on accelerating all stages of innovation worldwide and forming collaborations between entrepreneurs and Johnson & Johnson's global healthcare businesses. Johnson & Johnson Innovation provides scientists, entrepreneurs and emerging companies with one-stop access to science and technology experts who can facilitate collaborations across the pharmaceutical, medical device and consumer companies of Johnson & Johnson. Under the Johnson & Johnson Innovation umbrella of businesses, we connect with innovators through our regional Innovation Centers, Johnson & Johnson Innovation | JLABS, Johnson & Johnson Innovation - JJDC, and our Business Development teams to create customized deals and novel collaborations that speed development of innovations to solve unmet needs in patients. For more information please visit www.jnjinnovation.com or follow @JNJInnovation.
Share The Healthcare Commercialization Journey – Stories from entrepreneurs who have been there, or are on their way
Share Tweet